Literature DB >> 20452251

Experimental orthotopic prostate tumor in nude mice: techniques for local cell inoculation and three-dimensional ultrasound monitoring.

Matthias Saar1, Christina Körbel, Volker Jung, Henrik Suttmann, Rainer Grobholz, Michael Stöckle, Gerhard Unteregger, Michael D Menger, Jörn Kamradt.   

Abstract

OBJECTIVES: Orthotopic prostate cancer models are of great importance for cancer research. Orthotopic models in mice have been described previously. However, these studies lack a detailed methodological description and fail to define standards for local cell inoculation. Herein, we studied the effect of different protocols on tumor growth and report for the first time the use of high resolution ultrasound for monitoring of tumor growth.
MATERIALS AND METHODS: Orthotopic inoculation of DU 145 MN1 prostate cancer cells was performed in 30 nude mice varying (1) the amount of cells (5 × 10(5) vs. 5 × 10(4)), (2) the number of puncture sites, and (3) the addition of matrigel. Surgical complications such as recoil of cells through the injection canal and rupture of the prostatic capsule were monitored. Animals were tracked by ultrasound imaging after 4, 5, and 6 weeks. Autopsy and histology confirmed local tumor growth.
RESULTS: A take rate of 27/30 (90%) was observed. Growth of orthotopic prostate tumors was increased after inoculation of a large amount of cells under the capsule of 1 dorsal prostate lobe, but inoculation of small amounts of cells still induced local tumors. Noninvasive ultrasound examination allowed to identify orthotopic tumor formation and to monitor tumor growth in vivo. Addition of matrigel did not accelerate tumor growth. Complications like recoil (6.8%) or rupture of the prostate capsule (1.4%) were rare.
CONCLUSIONS: Inoculation of DU 145 MN1 cells under the prostate capsule with a defined procedure results in very high take rates. Ultrasound screening is feasible to repetitively monitor tumor growth.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452251     DOI: 10.1016/j.urolonc.2010.02.014

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  6 in total

1.  Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer.

Authors:  Maija P Valta; Hongjuan Zhao; Matthias Saar; Johanna Tuomela; Rosalie Nolley; Johannes Linxweiler; Jouko Sandholm; Jaakko Lehtimäki; Pirkko Härkönen; Ilsa Coleman; Peter S Nelson; Eva Corey; Donna M Peehl
Journal:  Clin Exp Metastasis       Date:  2016-02-12       Impact factor: 5.150

2.  [From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].

Authors:  M Saar; J Kamradt; V Jung; M Stöckle; G Unteregger
Journal:  Urologe A       Date:  2011-08       Impact factor: 0.639

3.  Assessment of anti-inflammatory tumor treatment efficacy by longitudinal monitoring employing sonographic micro morphology in a preclinical mouse model.

Authors:  Sanjay Tiwari; Jan H Egberts; Olena Korniienko; Linda Köhler; Anna Trauzold; Claus C Glüer; Holger Kalthoff
Journal:  BMC Med Imaging       Date:  2011-06-23       Impact factor: 1.930

Review 4.  Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX.

Authors:  Domenica Rea; Vitale Del Vecchio; Giuseppe Palma; Antonio Barbieri; Michela Falco; Antonio Luciano; Davide De Biase; Sisto Perdonà; Gaetano Facchini; Claudio Arra
Journal:  Biomed Res Int       Date:  2016-05-18       Impact factor: 3.411

5.  Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI.

Authors:  Johannes Linxweiler; Christina Körbel; Andreas Müller; Eva Jüngel; Roman Blaheta; Joana Heinzelmann; Michael Stöckle; Kerstin Junker; Michael D Menger; Matthias Saar
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

6.  Comparison of tumor angiogenesis in subcutaneous and orthotopic LNCaP mouse models using contrast-enhanced ultrasound imaging.

Authors:  Weiyong Liu; Yunkai Zhu; Lei Ye; Yajuan Zhu; Yuhao Wang
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.